Noetik Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 25

Noetik General Information

Description

Operator of an artificial intelligence native drug discovery company intended to develop cancer immunotherapies. The company's platform uses machine learning to identify new targets and design new treatments by harnessing the potential of self-supervised learning and human multimodal data, enabling the healthcare industry to target identification in preclinical research.

Contact Information

Website
www.noetik.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Tower Place
  • San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 2 Tower Place
  • San Francisco, CA 94080
  • United States
+1 (650)

Noetik Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noetik Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 23-Sep-2026 Completed Generating Revenue
3. Accelerator/Incubator 13-Sep-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 13-Aug-2024 $40M $54M Completed Generating Revenue
1. Seed Round 07-Sep-2023 $14M $14M Completed Generating Revenue
To view Noetik’s complete valuation and funding history, request access »

Noetik Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Series A-1
Seed 6,558,232 $0.000010 $1.22 $1.22 1x $1.22 13.03%
To view Noetik’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Noetik Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an artificial intelligence native drug discovery company intended to develop cancer immunotherapies. The com
Biotechnology
San Francisco, CA
45 As of 2026

San Francisco, CA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noetik Competitors (41)

One of Noetik’s 41 competitors is VeriSIM Life, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VeriSIM Life Venture Capital-Backed San Francisco, CA
20n Bio Venture Capital-Backed Philadelphia, PA
Verge Labs Venture Capital-Backed San Francisco, CA
Cyrus Biotechnology Venture Capital-Backed Seattle, WA
Metrum Research Group Corporation Simsbury, CT
You’re viewing 5 of 41 competitors. Get the full list »

Noetik Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Noetik Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250251320-A1 Methods and systems for analyzing images for precision tissue microarray construction Pending 07-Feb-2024
WO-2025171150-A1 Methods and systems for analyzing images for precision tissue microarray construction Pending 07-Feb-2024

Noetik Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noetik Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
AWS Startups Accelerator/Incubator
ApSTAT Technologies Holding Company Minority
Angel (individual) Minority
Angel (individual) Minority
Khosla Ventures Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

Ready to get started?

Request a free trial

Noetik FAQs

  • When was Noetik founded?

    Noetik was founded in 2022.

  • Where is Noetik headquartered?

    Noetik is headquartered in San Francisco, CA.

  • What is the size of Noetik?

    Noetik has 45 total employees.

  • What industry is Noetik in?

    Noetik’s primary industry is Biotechnology.

  • Is Noetik a private or public company?

    Noetik is a Private company.

  • What is Noetik’s current revenue?

    The current revenue for Noetik is .

  • How much funding has Noetik raised over time?

    Noetik has raised $54M.

  • Who are Noetik’s investors?

    AWS Startups, ApSTAT Technologies, , , and Khosla Ventures are 5 of 25 investors who have invested in Noetik.

  • Who are Noetik’s competitors?

    VeriSIM Life, 20n Bio, Verge Labs, Cyrus Biotechnology, and Metrum Research Group are some of the 41 competitors of Noetik.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process